CG
BMY icon

Caprock Group’s Bristol-Myers Squibb BMY Stock Holding History

Caprock Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.16M Buy
118,132
+41,997
+55% +$2.45M 0.17% 95
2025
Q4 		$4.11M Buy
76,135
+12,822
+20% +$617K 0.09% 193
2025
Q3 		$2.99M Buy
+63,313
New +$2.96M 0.07% 241
2025
Q1 		$4.72M Sell
77,386
-1,047
-1% -$61K 0.14% 119
2024
Q4 		$4.44M Buy
78,433
+17,796
+29% +$994K 0.15% 117
2024
Q3 		$3.14M Buy
60,637
+15,870
+35% +$744K 0.11% 156
2024
Q2 		$1.86M Buy
44,767
+16,069
+56% +$719K 0.08% 227
2024
Q1 		$1.56M Buy
28,698
+4,063
+16% +$207K 0.09% 176
2023
Q4 		$1.26M Sell
24,635
-4,452
-15% -$234K 0.08% 201
2023
Q3 		$1.69M Sell
29,087
-3,491
-11% -$214K 0.13% 124
2023
Q2 		$2.08M Buy
32,578
+2,176
+7% +$146K 0.15% 102
2023
Q1 		$2.11M Sell
30,402
-3,373
-10% -$238K 0.16% 99
2022
Q4 		$2.43M Buy
33,775
+409
+1% +$30.8K 0.23% 69
2022
Q3 		$2.37M Buy
33,366
+668
+2% +$48.5K 0.23% 63
2022
Q2 		$2.54M Buy
32,698
+280
+0.9% +$21.3K 0.25% 59
2022
Q1 		$2.38M Buy
32,418
+5,545
+21% +$372K 0.22% 69
2021
Q4 		$1.68M Sell
26,873
-3,571
-12% -$209K 0.14% 111
2021
Q3 		$1.82M Sell
30,444
-4,433
-13% -$292K 0.16% 89
2021
Q2 		$2.33M Buy
34,877
+6,985
+25% +$455K 0.21% 77
2021
Q1 		$1.77M Sell
27,892
-3,850
-12% -$240K 0.19% 84
2020
Q4 		$1.99M Buy
31,742
+2,268
+8% +$139K 0.23% 76
2020
Q3 		$1.78M Buy
29,474
+3,219
+12% +$194K 0.24% 72
2020
Q2 		$1.54M Buy
26,255
+2,468
+10% +$148K 0.23% 77
2020
Q1 		$1.33M Sell
23,787
-2,570
-10% -$157K 0.25% 78
2019
Q4 		$1.69M Buy
26,357
+4,520
+21% +$259K 0.3% 61
2019
Q3 		$1.11M Sell
21,837
-1,049
-5% -$49.3K 0.22% 87
2019
Q2 		$1.04M Sell
22,886
-413
-2% -$19.2K 0.2% 93
2019
Q1 		$1.11M Buy
23,299
+393
+2% +$19.6K 0.22% 94
2018
Q4 		$1.19M Buy
22,906
+2,412
+12% +$130K 0.27% 74
2018
Q3 		$1.27M Sell
20,494
-21
-0.1% -$1.25K 0.26% 73
2018
Q2 		$1.14M Sell
20,515
-2,894
-12% -$156K 0.24% 77
2018
Q1 		$1.48M Buy
23,409
+43
+0.2% +$2.77K 0.32% 59
2017
Q4 		$1.48M Sell
23,366
-1,326
-5% -$82.9K 0.29% 65
2017
Q3 		$1.57M Buy
24,692
+1,765
+8% +$103K 0.33% 59
2017
Q2 		$1.28M Buy
22,927
+8,600
+60% +$468K 0.28% 66
2017
Q1 		$779K Sell
14,327
-625
-4% -$34.3K 0.18% 106
2016
Q4 		$874K Sell
14,952
-1,264
-8% -$69.1K 0.22% 95
2016
Q3 		$874K Sell
16,216
-157
-1% -$10.1K 0.2% 116
2016
Q2 		$1.2M Sell
16,373
-1,016
-6% -$71.8K 0.29% 85
2016
Q1 		$1.11M Buy
+17,389
New +$1.1M 0.26% 86

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Caprock Group's BMY Position: Q1 2026 in Review

Caprock Group increased its Bristol-Myers Squibb (BMY) stake by 55% in Q1 2026, buying an estimated $2.45M and bringing the position to 118,132 shares worth $7.16M. The position accounts for 0.17% of the portfolio, ranked #95.

Caprock Group first reported a position in BMY in Q1 2016 and has held it in 40 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Caprock Group held 118,132 shares of Bristol-Myers Squibb worth $7.16M as of Q1 2026.
  • Caprock Group bought 41,997 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.45M.
  • Bristol-Myers Squibb made up 0.17% of Caprock Group's portfolio in Q1 2026, its #95 holding.
  • Caprock Group first reported a position in Bristol-Myers Squibb in Q1 2016 and has held it in 40 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Caprock Group's 13F filing for Q1 2026, filed 11 May 2026.